U.S. government researchers found that a resurgence of COVID symptoms after taking Pfizer’s Paxlovid antiviral COVID medication may be related to a robust immune system response.
U.S. government researchers found that a resurgence of COVID symptoms after taking Pfizer’s Paxlovid antiviral COVID medication may be related to a robust immune system response.